• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.05% Nasdaq Down0.18%

    Albany Molecular Research Inc. (AMRI)

    -NasdaqGS
    15.04 Up 0.28(1.90%) May 5, 4:00PM EDT
    |After Hours : 15.04 0.00 (0.00%) May 5, 4:37PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
    Total Revenue 126,412   104,579   89,549   81,816  
    Cost of Revenue92,516  80,198  64,846  58,521  
    Gross Profit 33,896   24,381   24,703   23,295  
    Operating Expenses
    Research Development2,696  1,903  385  490  
    Selling General and Administrative22,183  21,219  16,518  17,474  
    Non Recurring2,775  1,249  1,632  4,102  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 6,242   10   6,168   1,229  
    Income from Continuing Operations
    Total Other Income/Expenses Net333  798  634  469  
    Earnings Before Interest And Taxes6,575  808  6,802  1,698  
    Interest Expense6,820  6,318  3,178  3,036  
    Income Before Tax(245)(5,510)3,624  (1,338)
    Income Tax Expense(2,030)(1,340)1,317  885  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops1,785  (4,170)2,307  (2,223)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 1,785   (4,170) 2,307   (2,223)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 1,785   (4,170) 2,307   (2,223)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.